SCNI
Scinai Immunotherapeutics
SCNI • NASDAQ
Scinai Immunotherapeutics is a biological products, (no disgnostic substances) company trading on NASDAQ, led by CEO Amir Reichman.
CEOAmir Reichman
Next Earnings
Upcoming earnings announcement for Scinai Immunotherapeutics
Date
Wednesday, May 6, 2026 (in 3 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Scinai Immunotherapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | FY 2025 | -$3.56 | — | $1.3M | — | — |
| May 7, 2025 | Q4 2024 | -$9.57 | — | $206.0K | — | — |
| Nov 22, 2024 | Q3 2024 | -$8.40 | — | $168.0K | — | — |
| Aug 15, 2024 | Q2 2024 | -$4.00 | — | $284.0K | — | — |
| Jul 2, 2024 | Q1 2024 | -$4.00 | — | - | — | — |
| May 15, 2024 | Q4 2023 | -$8.00 | — | - | — | — |
| Oct 31, 2023 | Q3 2023 | -$0.02 | — | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$1.20Est: -$0.91 | -31.9% | - | — | — |
| May 15, 2023 | Q1 2023 | -$1.20Est: -$0.73 | -64.4% | - | — |  10-Q |
| Apr 17, 2023 | Q4 2022 | $0.00Est: -$0.10 | +100.0% | - | — | 10-K |
| Nov 30, 2022 | Q3 2022 | $0.06Est: -$0.10 | +160.0% | - | — | — |
| Aug 25, 2022 | Q2 2022 | -$2.00Est: -$1.00 | -100.0% | - | — | — |